Innate Pharma
(IPHYF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 227,233 | 179,883 | 112,315 | 194,658 | 169,640 |
| Marketable Securities | 17,895 | 17,971 | 18,925 | 24,104 | 92,150 |
| Receivables | 20,989 | 179,762 | 24,202 | 35,843 | 17,995 |
| Other current assets | 0 | -118 | -1 | 0 | 0 |
| TOTAL | $266,118 | $377,498 | $155,440 | $254,604 | $279,784 |
| Non-Current Assets | |||||
| PPE Net | 13,073 | 12,065 | 12,127 | 10,063 | 6,996 |
| Intangibles | 108,604 | 99,829 | 52,211 | 10,042 | 10,800 |
| Other Non-Current Assets | 61,731 | 43,494 | 68,474 | 36,883 | 41,940 |
| TOTAL | $183,408 | $155,388 | $132,811 | $56,989 | $59,735 |
| Total Assets | $449,524 | $532,886 | $288,253 | $311,593 | $339,519 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 55,445 | 108,245 | 27,870 | 22,425 | 66,073 |
| Other current liabilities | 26,374 | 26,377 | 1,518 | 1,399 | 690 |
| TOTAL | $136,441 | $231,576 | $83,539 | $84,590 | $66,763 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 54,622 | 96,955 | 54,152 | 60,766 | N/A |
| Other Non-Current Liabilities | 22,955 | 21,531 | 9,216 | 7,322 | 192,784 |
| TOTAL | $69,578 | $103,798 | $107,558 | $131,647 | $192,784 |
| Total Liabilities | $206,018 | $335,375 | $191,096 | $216,236 | $259,547 |
| Shareholders' Equity | |||||
| Common Shares | 4,414 | 3,776 | 3,255 | 2,983 | 2,987 |
| Retained earnings | -151,101 | -162,789 | -117,093 | -128,626 | -121,540 |
| Other shareholders' equity | -23,778 | 4,899 | -54,484 | 13,431 | -8,253 |
| TOTAL | $243,506 | $200,105 | $97,156 | $95,355 | $79,973 |
| Total Liabilities And Equity | $449,524 | $535,480 | $288,253 | $311,591 | $339,519 |